Graft-Versus-Host Disease (GVHD) Market 2028 By Product Type inhibitors, Treatment Type, Distribution Channel and Geography | The Insight Partners

report image

Graft-Versus-Host Disease (GVHD) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Corticosteroids, ATG therapies, IL2R alpha (CD25) inhibitors, TNF alpha inhibitors, Calcineurin inhibitors, MTOR inhibitors, SOT therapies, Anti-neoplastic therapies, Stem Cell Treatments, Extracorporeal Photophoresis, Other biologics); Treatment Type (Prophylaxis GVHD, Chronic GVHD, Acute GVHD); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00006856 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Graft-versus-host disease (GVHD) is a medical condition that occurs after organ transplants that happens when the donor's immune cells attack the recipient's organ tissues. This is a common complication that occurs after an allogeneic bone marrow transplant (stem cell transplant). The disease's symptoms range from minor to severe and life-threatening, and it frequently results in diseases such as jaundice, skin inflammation, and others. The key driving factors for the graft-versus-host disease (GVHD) market are, increasing bone marrow transplants and increasing number of surgeries.


The "Global Graft-Versus-Host Disease (GVHD) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the graft-versus-host disease (GVHD) market with detailed market segmentation by product type, treatment type and distribution channel. The report provides key statistics on the market status of the leading graft-versus-host disease (GVHD) market players and offers key trends and opportunities in the market.


  •   Based on product type the market is segmenetd as, corticosteroids, ATG therapies, IL2R (CD25) inhibitors, TNF inhibitors, Calcineurin inhibitors, mTOR inhibitors, SOT therapies, anti-neoplastic therapies, stem cell treatments, extracorporeal photophoresis and other biologics.
  •   Based on treatment type the market is segmented as, prophylaxis GVHD, chronic GVHD, acute GVHD.
  •   Based on distribution channel the market is segmented as, hospital pharmacies, retail pharmacies and online pharmacies.


  •   Increasing prevalence of GVHD disorder owing to rising allogenic stem cell transplant is the key driver for the market growth.
  •   Rising demand for bone marrow transplants, increasing bone marrow transplant procedures.
  •   Rising awareness and demand about cell therapies is also expected to spur the market growth.


  •   However, high cost associated with GVHD is likely to restrain market growth during the forecast period.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The graft-versus-host disease (GVHD) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the graft-versus-host disease (GVHD) market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Get more information on this report :


The report covers key developments in the graft-versus-host disease (GVHD) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from graft-versus-host disease (GVHD) market are anticipated to lucrative growth opportunities in the future with the rising demand for graft-versus-host disease (GVHD) in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the graft-versus-host disease (GVHD) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Novartis AG
  •   Bristol-Myers Squibb Company
  •   Pfizer, Inc
  •   Neovii Pharmaceuticals AG
  •   AbbVie Inc
  •   Astellas Pharma Inc
  •   Merck KGaA
  •   Soligenix
  •   Genentech, Inc
  •   Incyte
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Novartis AG
2. Bristol-Myers Squibb Company
3. Pfizer, Inc
4. Neovii Pharmaceuticals AG
5. AbbVie Inc
6. Astellas Pharma Inc
7. Merck KGaA
8. Soligenix
9. Genentech, Inc
10. Incyte
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount